{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:22:15Z","timestamp":1787887335464,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122033"],"award-info":[{"award-number":["82122033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871379"],"award-info":[{"award-number":["81871379"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959208"],"award-info":[{"award-number":["91959208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971646"],"award-info":[{"award-number":["81971646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82220108004"],"award-info":[{"award-number":["82220108004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key project from National Science and Technology Council","award":["2017-JCJQ-ZD-051-04"],"award-info":[{"award-number":["2017-JCJQ-ZD-051-04"]}]},{"name":"Clinical Research Project of AFMU","award":["2021LC2111"],"award-info":[{"award-number":["2021LC2111"]}]},{"name":"Clinical Research Project of AFMU","award":["2021LC2220"],"award-info":[{"award-number":["2021LC2220"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11307-023-01841-6","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T11:30:05Z","timestamp":1690284605000},"page":"887-896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["PI-RADS-Based Segmented Threshold of PSMA-PET SUVmax Is Better than Traditional Fixed Threshold for Diagnosing Clinically Significant Prostate Cancer Especially for PI-RADS 3 Lesions"],"prefix":"10.1007","volume":"25","author":[{"given":"Xiaoli","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-7819","authenticated-orcid":false,"given":"Fei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"1841_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1841_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"1841_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","volume":"33","author":"L Klotz","year":"2015","unstructured":"Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients withprostate cancer. J Clin Oncol 33:272\u2013277","journal-title":"J Clin Oncol"},{"key":"1841_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618\u2013629","journal-title":"Eur Urol"},{"key":"1841_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiol.2021204112","volume":"300","author":"D Deniffel","year":"2021","unstructured":"Deniffel D, Healy GM, Dong X et al (2021) Avoiding unnecessary biopsy: MRI-based risk models versus a PI-RADS and PSA density strategy for clinically significant prostate cancer. Radiology 300:369\u2013379","journal-title":"Radiology"},{"key":"1841_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1148\/radiol.2018172619","volume":"288","author":"PR Shankar","year":"2018","unstructured":"Shankar PR, Kaza RK, Al-Hawary MM et al (2018) Impact of clinical history on maximum PI-RADS version 2 score: a six-reader 120-case sham history retrospective evaluation. Radiology 288:158\u2013163","journal-title":"Radiology"},{"key":"1841_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.2017161316","volume":"285","author":"MD Greer","year":"2017","unstructured":"Greer MD, Shih JH, Lay N et al (2017) Validation of the dominant sequence paradigm and role of dynamic contrast-enhanced imaging in PIRADS version 2. Radiology 285:859\u2013869","journal-title":"Radiology"},{"key":"1841_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"1841_CR9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"1841_CR10","first-page":"CD012663","volume":"4","author":"FH Drost","year":"2019","unstructured":"Drost FH, Osses DF, Nieboer D et al (2019) Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev 4:CD012663","journal-title":"Cochrane Database Syst Rev"},{"key":"1841_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M et al (2013) PET imaging with a [68Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumor lesions. Eur J Nucl Med Mol Imaging 40:486\u2013495","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1841_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/ph14080713","volume":"14","author":"U Hennrich","year":"2021","unstructured":"Hennrich U, Eder M (2021) [68Ga] Ga-PSMA-11: the first FDA-approved 68Ga-radiopharmaceutical for PET imaging of prostate cancer. Pharmaceuticals (Basel) 14:713","journal-title":"Pharmaceuticals (Basel)"},{"key":"1841_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2967\/jnumed.117.195255","volume":"59","author":"SP Rowe","year":"2018","unstructured":"Rowe SP, Pienta KJ, Pomper MG et al (2018) Proposal for a structured reporting system for prostate-specific membrane antigen-targeted PET imaging: PSMA-RADS Version 1.0. J Nucl Med 59:479\u2013485","journal-title":"J Nucl Med"},{"key":"1841_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1148\/radiol.2021204093","volume":"301","author":"D Margel","year":"2021","unstructured":"Margel D, Bernstine H, Groshar D et al (2021) Diagnostic performance of (68) Ga prostate-specific membrane antigen PET\/MRI compared with multiparametric MRI for detecting clinically significant prostate cancer. Radiology 301:379\u2013386","journal-title":"Radiology"},{"key":"1841_CR15","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.7150\/thno.58140","volume":"11","author":"J Jiao","year":"2021","unstructured":"Jiao J, Kang F, Zhang J et al (2021) Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by (68) Ga-PSMA PET\/CT: a real-world study. Theranostics 11:8396\u20138411","journal-title":"Theranostics"},{"key":"1841_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.euo.2021.02.006","volume":"5","author":"AA Kalapara","year":"2022","unstructured":"Kalapara AA, Ballok ZE, Ramdave S et al (2022) Combined utility of 68Ga-prostate-specific membrane antigen positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging in predicting prostate biopsy pathology. Eur Urol Oncol 5:314\u2013320","journal-title":"Eur Urol Oncol"},{"key":"1841_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1200\/jco.2016.34.2_suppl.10","volume":"34","author":"A Katz","year":"2016","unstructured":"Katz A, Liu C, Kosinski K (2016) Histopathologic correlation of PI-RADS V.2 lesions on 3T multiparametric prostate MRI. J Clin Oncol 34:10","journal-title":"J Clin Oncol"},{"key":"1841_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12967-017-1333-2","volume":"15","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Zang S, Zhang C et al (2017) Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer. J Transl Med 15:230","journal-title":"J Transl Med"},{"key":"1841_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M et al (2017) (68) Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging 44:1014\u20131024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1841_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/cancers14020270","volume":"14","author":"PW Mihatsch","year":"2022","unstructured":"Mihatsch PW, Beissert M, Pomper MG et al (2022) Changing threshold-based segmentation has no relevant impact on semi-quantification in the context of structured reporting for PSMA-PET\/CT. Cancers (Basel) 14:270","journal-title":"Cancers (Basel)"},{"key":"1841_CR21","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00330-009-1428-0","volume":"19","author":"J Ren","year":"2009","unstructured":"Ren J, Huan Y, Wang H et al (2009) Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 19:2481\u20132486","journal-title":"Eur Radiol"},{"key":"1841_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00259-018-4255-1","volume":"46","author":"J Zhang","year":"2019","unstructured":"Zhang J, Shao S, Wu P et al (2019) Diagnostic performance of 68Ga-PSMA PET\/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms. Eur J Nucl Med Mol Imaging 46:908\u2013920","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1841_CR23","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","volume":"44","author":"G van Leenders","year":"2020","unstructured":"van Leenders G, van der Kwast TH, Grignon DJ et al (2020) The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol 44:e87\u2013e99","journal-title":"Am J Surg Pathol"},{"key":"1841_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAP.0000000000000287","volume":"28","author":"SC Smith","year":"2021","unstructured":"Smith SC, Gandhi JS, Moch H et al (2021) Similarities and differences in the 2019 ISUP and GUPS recommendations on prostate cancer grading: a guide for practicing pathologists. Adv Anat Pathol 28:1\u20137","journal-title":"Adv Anat Pathol"},{"key":"1841_CR25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.juro.2016.02.3000","volume":"196","author":"H Rhee","year":"2016","unstructured":"Rhee H, Thomas P, Shepherd B et al (2016) Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer. J Urol 196:1261\u20131267","journal-title":"J Urol"},{"key":"1841_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C et al (2017) 68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumor. Eur J Nucl Med Mol Imaging 44:941\u2013949","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1841_CR27","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00330-016-4479-z","volume":"27","author":"PJ De Visschere","year":"2017","unstructured":"De Visschere PJ, Vral A, Perletti G et al (2017) Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate. Eur Radiol 27:2095\u20132109","journal-title":"Eur Radiol"},{"key":"1841_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00261-008-9382-x","volume":"34","author":"A Prando","year":"2009","unstructured":"Prando A, Billis A (2009) Focal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studies. Abdom Imaging 34:271\u2013275","journal-title":"Abdom Imaging"},{"key":"1841_CR29","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00330-013-2795-0","volume":"23","author":"F Bratan","year":"2013","unstructured":"Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localization on multiparametric MRI: a prospective study. Eur Radiol 23:2019\u20132029","journal-title":"Eur Radiol"},{"key":"1841_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnmrs.2018.01.001","volume":"105","author":"V Kumar","year":"2018","unstructured":"Kumar V, Bora GS, Kumar R, Jagannathan NR (2018) Multiparametric (mp) MRI of prostate cancer. Prog Nucl Magn Reson Spectrosc 105:23\u201340","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"1841_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.eururo.2018.05.035","volume":"75","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J (2019) Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 status update and future directions. Eur Urol 75:385\u2013396","journal-title":"Eur Urol"},{"key":"1841_CR32","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.juro.2012.01.074","volume":"187","author":"AB Rosenkrantz","year":"2012","unstructured":"Rosenkrantz AB, Mendrinos S, Babb JS, Taneja SS (2012) Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. J Urol 187:2032\u20132038","journal-title":"J Urol"},{"key":"1841_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1148\/radiology.189.2.8210358","volume":"189","author":"ML Schiebler","year":"1993","unstructured":"Schiebler ML, Schnall MD, Pollack HM et al (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339\u2013352","journal-title":"Radiology"},{"key":"1841_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00259-020-05025-0","volume":"48","author":"L Evangelista","year":"2021","unstructured":"Evangelista L, Zattoni F, Cassarino G et al (2021) PET\/MRI in prostate cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 48:859\u2013873","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1841_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.118.221010","volume":"60","author":"M Chen","year":"2019","unstructured":"Chen M, Zhang Q, Zhang C et al (2019) Combination of (68) Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis. J Nucl Med 60:944\u2013949","journal-title":"J Nucl Med"},{"key":"1841_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","volume":"46","author":"P Donato","year":"2019","unstructured":"Donato P, Roberts MJ, Morton A et al (2019) Improved specificity with (68) Ga PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging 46:20\u201330","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1841_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.juro.2018.01.079","volume":"200","author":"E Lopci","year":"2018","unstructured":"Lopci E, Saita A, Lazzeri M et al (2018) 68Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study. J Urol 200:95\u2013103","journal-title":"J Urol"},{"key":"1841_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1148\/radiol.2018180788","volume":"289","author":"RM Hicks","year":"2018","unstructured":"Hicks RM, Simko JP, Westphalen AC et al (2018) Diagnostic accuracy of 68Ga-PSMA-11 PET\/MRI compared with multiparametric MRI in the detection of prostate cancer. Radiology 289:730\u2013737","journal-title":"Radiology"},{"key":"1841_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2967\/jnumed.121.262398","volume":"63","author":"I Sonni","year":"2022","unstructured":"Sonni I, Felker ER, Lenis AT et al (2022) Head-to-head comparison of 68Ga-PSMA-11 PET\/CT and mpMRI with a histopathology gold standard in the detection, intraprostatic localization, and determination of local extension of primary prostate cancer: results from a prospective single-center imaging trial. J Nucl Med 63:847\u2013854","journal-title":"J Nucl Med"},{"key":"1841_CR40","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2967\/jnumed.117.190314","volume":"58","author":"SA Koerber","year":"2017","unstructured":"Koerber SA, Utzinger MT, Kratochwil C et al (2017) 68Ga-PSMA-11 PET\/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters. J Nucl Med 58:1943\u20131948","journal-title":"J Nucl Med"},{"key":"1841_CR41","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2967\/jnumed.116.172627","volume":"57","author":"WP Fendler","year":"2016","unstructured":"Fendler WP, Schmidt DF, Wenter V et al (2016) 68Ga-PSMA PET\/CT detects the location and extent of primary prostate cancer. J Nucl Med 57:1720\u20131725","journal-title":"J Nucl Med"},{"key":"1841_CR42","first-page":"1644","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett L, Papa N, Buteau J et al (2022) The PRIMARY Score: using intra-prostatic PSMA PET\/CT patterns to optimise prostate cancer diagnosis. J Nucl Med 63:1644\u20131650","journal-title":"J Nucl Med"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01841-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:16:28Z","timestamp":1698149788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01841-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1841"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01841-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2794409\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}